Inogen Announces Preliminary, Unaudited Full Year and Fourth Quarter 2021 Revenue Results

2 years ago

– Q4 2021 Total Preliminary Revenue of $75.9 to $76.9 million – – Provides Supply Chain and EU Operations Update…

U.S. Digital Health Market Report 2021-2028: Rise in Public-Private Partnerships, Digital Infrastructure Developments, Increasing Healthcare IT Expenditure, and Growing Government Support – ResearchAndMarkets.com

2 years ago

DUBLIN--(BUSINESS WIRE)--The "U.S. Digital Health Market Size, Share & Trends Analysis Report by Technology (mHealth, Healthcare Analytics, Tele-healthcare), by Component…

Quadient Secures Supplier Status on NHS Shared Business Services Framework Agreement

2 years ago

Quadient included on three Lots for patient/citizen communications and engagement solutions London, 10 January, 2022 Quadient UK, a leader in…

Defence Therapeutics Achieves a Major Milestone and Begins IND-Enabling Testing of Its AccuTOX Lead Compound Against Breast Cancer

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - January 10, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"…

RepliCel Announces Material Patent Milestones

2 years ago

New DermaPrecise™ patent application and patents granted for tendinopathy and skin rejuvenation technologies in key marketsVANCOUVER, BC / ACCESSWIRE /…

XPhyto Announces New Director of Business Development and Head of Diagnostic Research

2 years ago

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / January 10, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company")…

MorphoSys To Present At the 40th Annual J.P. Morgan Healthcare Conference

2 years ago

PLANEGG / MUNICH, GERMANY / ACCESSWIRE / Janauary 10, 2022 / MorphoSys AG (FSE:MOR; NASDAQ:MOR), announced today that Jean-Paul Kress,…

Angle PLC Announces Insight into Drug Resistance in NSCLC

2 years ago

EPIGENETIC ALTERATIONS IN GENES FROM LIQUID BIOPSIES PROVIDE INSIGHT INTO DRUG RESISTANCE IN NON-SMALL LUNG CANCER PATIENTSLongitudinal analysis of paired…

Xlife Sciences AG Plans Listing on the ‘Sparks’ Segment of SIX Swiss Exchange

2 years ago

Listing on the new "Sparks" segment of SIX Swiss Exchange for small and medium-sized companies is planned for Q1 2022,…

Sativa Wellness Group Announces Name Change and Strategic Update

2 years ago

VANCOUVER, BC / ACCESSWIRE / January 9, 2022 / Sativa Wellness Group Inc. (CSE:SWEL) ("Sativa Wellness" or the "Company") is…